###begin article-title 0
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-interferon antibody fragment and human interferon alpha-2A
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
###end p 1
###begin p 2
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
Crystals of the complex between the Fab fragment of a human anti-interferon alpha therapeutic antibody and human interferon alpha-2A have been obtained and diffracted to 3.0 A resolution.
###end p 2
###begin p 3
###xml 401 402 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 409 410 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 411 412 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 413 414 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 415 416 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 444 445 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 456 457 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 468 469 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 666 667 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 667 668 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 679 680 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 683 685 663 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
Recombinant human interferon alpha-2A (rhIFN-alpha-2A) has been crystallized in complex with the recombinantly produced Fab fragment of a therapeutic monoclonal antibody (MEDI545; IgG1/kappa) which targets several human inter-feron alpha subtypes. This constitutes the first reported crystals of a human type I interferon bound to an antibody. The orthorhombic crystals belonged to either space group I222 or I212121, with unit-cell parameters a = 134.82, b = 153.26, c = 163.49 A. The diffraction of the crystals extended to 3.0 A resolution. The asymmetric unit contained two Fab-rhIFN-alpha-2A complexes. This corresponded to a crystal volume per protein weight (VM) of 3.02 A3 Da-1 and a solvent content of 59.3%. The corresponding three-dimensional structure is expected to shed light on the mechanism of action of MEDI545 and the molecular basis of its specificity.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 385 387 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb6"> &#9654;</xref>
###xml 397 403 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 409 411 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb5"> &#9654;</xref>
###xml 423 429 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 435 437 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb1"> &#9654;</xref>
###xml 569 575 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 581 583 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb2"> &#9654;</xref>
###xml 600 606 572 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 612 614 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb14"> &#9654;</xref>
###xml 707 709 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb4"> &#9654;</xref>
###xml 844 850 812 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 856 858 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb13"> &#9654;</xref>
###xml 953 958 <span type="species:ncbi:9606">human</span>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
Type I interferons (IFNs) are a family of cytokines that are expressed from over 15 functional genes and include IFN-alpha, IFN-beta, IFN-tau, IFN--kappa, IFN-∊, IFN-delta and IFN-omega. Interferons, in particular IFN-alpha and IFN-beta, have historically been characterized in terms of their role in modulating the responses of mammalian hosts to infections (Isaacs & Lindenmann, 1957 ▶; Gresser et al., 1976 ▶; Alsharifi et al., 2008 ▶). How-ever, it is becoming increasingly clear that they also play a key role in immune regulation and autoimmune diseases (Baccala et al., 2005 ▶; Theofilopoulos et al., 2005 ▶). The IFN-alpha family alone comprises at least 13 different subtypes (Foster & Finter, 1998 ▶) and is thought to play a role in systemic lupus erythematosus (SLE), type I diabetes, Sjogren's syndrome and thyroid diseases (Selmi et al., 2006 ▶). This attractive targeting potential led to the development by MedImmune of MEDI545, a fully human monoclonal antibody which exhibits binding to multiple IFN-alpha subtypes. MEDI545 is currently undergoing several human clinical trials for various indications such as lupus, chronic plaque psoriasis, dermatomyositis and poliomyelitis ().
###end p 5
###begin p 6
###xml 435 441 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 447 449 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb12"> &#9654;</xref>
###xml 460 466 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 472 474 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb8"> &#9654;</xref>
###xml 482 488 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 494 496 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb9"> &#9654;</xref>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 550 555 <span type="species:ncbi:9606">human</span>
In an effort to better understand the molecular basis of the recognition of IFN-alpha molecules by MEDI545, we set out to solve the X-ray crystal structure of the complex between the Fab fragment of this antibody and human IFN-alpha-2A. Three type I human interferon structures have previously been determined using either X-ray crystallography or NMR. These correspond to human IFN-alpha-2a, IFN--alpha-2b and IFN-beta (Radhakrishnan et al., 1996 ▶; Karpusas et al., 1997 ▶; Klaus et al., 1997 ▶). Here, the first reported diffracting crystals of a human type I interferon bound to an antibody are described and characterized.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Expression and purification of MEDI545 Fab and rhIFN-alpha-2a
###end title 8
###begin p 9
###xml 283 289 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 295 297 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb3"> &#9654;</xref>
###xml 527 533 519 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 539 541 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb7"> &#9654;</xref>
###xml 597 603 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 609 611 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb10"> &#9654;</xref>
###xml 947 948 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 976 977 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1253 1255 1241 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 186 207 <span type="species:ncbi:10359">human cytomegalovirus</span>
###xml 345 349 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 427 432 <span type="species:ncbi:9606">human</span>
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 666 671 <span type="species:ncbi:9606">human</span>
The heavy and light chains of the Fab fragment of MEDI545 (IgG1/kappa) were cloned into a mammalian expression vector. More precisely, each chain was placed under the control of its own human cytomegalovirus major immediate early (hCMVie) promoter and enhancer (described in Boshart et al., 1985 ▶). Each of those two genes also incorporated an SV40 poly-A sequence to allow proper pro-cessing of its 3' end. In this system, a human gamma1 chain truncated at position Lys235 (according to the Kabat numbering convention; Kabat et al., 1991 ▶) is secreted along with a human kappa chain (Oganesyan et al., 2008 ▶). The construct was then transiently transfected into human embryonic kidney (HEK) 293 cells using Lipofectamine (Invitrogen, Carlsbad, California, USA) and standard protocols. MEDI545 Fab was typically harvested 72, 144 and 216 h post-transfection. Conditioned media containing the soluble Fab fragment were then dialyzed against 50 mM sodium acetate pH 5.2, 20 mM NaCl and purified using a HiTrap HP SP column in a NaCl gradient according to the manufacturer's instructions (GE Healthcare, Piscataway, New Jersey, USA). Purified MEDI545 Fab, typically >95% homogeneous as judged by SDS-PAGE, was then concentrated to approximately 30 mg ml-1.
###end p 9
###begin p 10
###xml 37 53 37 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 533 535 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 670 671 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 699 700 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 734 736 722 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 821 823 809 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
High-quality nearly 100% homogeneous Escherichia coli-expressed recombinant human interferon alpha-2A (rhIFN-alpha-2A) was purchased directly from Potomac Affinity Proteins LLC (Rockville, Maryland, USA). The cytokine's mature sequence corresponded to residues 24-188 of entry No. P01563 of the Swiss-Prot protein database () and included two extra threonine and serine residues on its N-terminal end. MEDI545 Fab and rhIFN-alpha-2A were mixed in a 1.2:1 molar ratio. The resulting mixture was then adjusted to approximately 10 mg ml-1. The complex was further purified by size-exclusion chromatography using a Superdex S200 column (GE Healthcare) equilibrated with 20 mM sodium acetate pH 5.2, 20 mM NaCl at a flow rate of 0.5 ml min-1. After separation from excess MEDI545 Fab, the complex was concentrated to 6.5 mg ml-1 using an Amicon YM-30 concentrator (Millipore, Billerica, Massachusetts, USA).
###end p 10
###begin title 11
Crystallization screening and optimization
###end title 11
###begin p 12
###xml 923 925 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1331 1333 1299 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1477 1477 1434 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="sec3"/>
###xml 435 440 <span type="species:ncbi:111540">Aliso</span>
Sitting-drop crystallization experiments were initially set up in 96--well plates with conical flat-bottomed drop compartments (Corning 3785; VWR, West Chester, Pennsylvania, USA) using a Phoenix crystallization robot (Art Robbins, Sunnyvale, California, USA). Favorable conditions were initially identified using the following commercially available crystallization screens: Crystal Screen HT, Index Screen, SaltRx (Hampton Research, Aliso Viejo, California, USA) and ProPlex (Molecular Dimensions, Apopka, Florida, USA). For further optimization purposes, a commercially available kit was used (Additive Screen HT; Hampton Research). More particularly, in screening mode the reservoirs and drop compartments of the 96-well plates were filled with 99 and 0.3 microl, respectively, of the various screen solutions using the Phoenix robot. 0.3 microl of the MEDI545 Fab-rhIFN-alpha-2A complex at a concentration of 6.5 mg ml-1 was then added to the drop compartment. In optimization mode, the reservoirs were first filled with 80 microl screen solution. 20 microl of the various additives were then added and the reservoirs were subjected to five cycles of mixing by aspiration/dispensing. 0.3 microl of each reservoir solution was then mixed with 0.3 microl of the MEDI545 Fab-rhIFN-alpha-2A complex at a concentration of 6.5 mg ml-1 in the drop compartment. Diffraction-quality crystals were grown in hanging drops once optimal conditions had been identified (see section sign3).
###end p 12
###begin title 13
X-ray diffraction data collection and processing
###end title 13
###begin p 14
###xml 258 260 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 539 540 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 555 556 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 559 560 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</italic>
###xml 592 593 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 860 863 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HKL</italic>
###xml 894 896 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb11"> &#9654;</xref>
Diffraction data were collected from a single crystal at the Center for Advanced Research in Biotechnology (CARB, University of Maryland Biotechnology Institute, Rockville, Maryland, USA) using a MicroMax-007 rotating-anode generator fitted with an R-AXIS IV++ imaging plate (Rigaku/MSC, The Woodlands, Texas, USA). The crystal was harvested using a litho-loop and flash-cooled in a liquid-nitrogen stream using an X-stream 2000 cryogenic cooler (Rigaku/MSC). Prior to this step, cryoprotection was achieved by soaking the crystal in 200 mM NaI, 8 mM NiCl2.6H2O, 80 mM Tris-HCl pH 8.5, 16%(w/v) polyethylene glycol monomethyl ether 2000, 20% glycerol. 240 consecutive images were collected using an oscillation range of 0.5degrees, a crystal-to-detector distance of 250 mm and an exposure time of 600 s. The diffraction images were integrated and scaled using HKL-2000 (Otwinowski & Minor, 1997 ▶).
###end p 14
###begin title 15
Results and discussion
###end title 15
###begin p 16
###xml 162 163 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 168 169 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 173 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 203 204 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</italic>
###xml 205 206 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 268 270 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1"> &#9654;</xref>
###xml 271 272 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 477 478 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 493 494 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 521 522 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 706 708 694 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 716 717 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 745 746 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 876 877 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 886 887 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 892 893 876 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 896 897 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 904 905 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 927 928 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</italic>
###xml 929 930 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 1080 1082 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1"> &#9654;</xref>
###xml 1083 1084 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
Crystals of less than 10 microm in size and of tetragonal bipyramidal shape appeared during the screening process with Crystal Screen HT under condition H9 [0.01 M NiCl2.6H2O, 0.1 M Tris-HCl pH 8.5, 20%(w/v) polyethylene glycol monomethyl ether 2000] as seen in Fig. 1 ▶(a). During the optimization process, crystals of similar morphology appeared in almost all of the conditions of the Additive Screen. However, the largest crystals were obtained when using additives B8 (1.0 M NaI), D3 (0.1 M spermine-HCl) and D4 [0.1 M cobalt(III) hexammine chloride]. Hanging drops were then set up under those various conditions using 1 microl of the MEDI545 Fab-rhIFN-alpha-2A complex at a concentration of 3.5 mg ml-1 in 20 mM sodium acetate pH 5.2, 20 mM NaCl and 1 microl of the appropriate reservoir solutions. Diffraction-quality orthorhombic crystals grew in about 15 d when 200 mM NaI, 8 mM NiCl2.6H2O, 80 mM Tris-HCl pH 8.5, 16%(w/v) polyethylene glycol monomethyl ether 2000 was used as the reservoir solution. They reached dimensions of up to 0.1 x 0.1 x 0.2 mm, as seen in Fig. 1 ▶(b).
###end p 16
###begin p 17
###xml 173 175 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2"> &#9654;</xref>
###xml 328 329 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 362 368 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 374 376 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bb7"> &#9654;</xref>
###xml 476 478 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2"> &#9654;</xref>
###xml 136 141 <span type="species:ncbi:9606">human</span>
SDS-PAGE analysis of these crystals confirmed that they indeed contained the expected complex formed by MEDI545 Fab and the recombinant human interferon alpha-2A (see Fig. 2 ▶). Incidentally, the SDS-PAGE profile of MEDI545 Fab also demonstrated the presence of the expected interchain disulfide bond between Ckappa/Cys214 and CH1/Cys233 (Kabat numbering; Kabat et al., 1991 ▶) owing to its differential migration pattern under reducing and nonreducing con-ditions (see Fig. 2 ▶).
###end p 17
###begin p 18
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3"> &#9654;</xref>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 295 296 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 296 297 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 307 308 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 311 313 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="table1"> &#9654;</xref>
The diffraction limit of the crystal was 3.0 A (see Fig. 3 ▶). The possible space groups were determined to be either I222 or I212121, with unit-cell parameters a = 134.82, b = 153.26, c = 163.49 A. The asymmetric unit contained two MEDI545 Fab-rhIFN-alpha-2A com-plexes. This corresponded to a VM of 3.02 A3 Da-1 and a solvent content of 59.3%. Data-collection statistics are shown in Table 1 ▶. Structure determination using molecular replacement is currently under way.
###end p 18
###begin p 19
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 208 212 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
We are grateful to Potomac Affinity Proteins LLC (Rockville, Maryland, USA) for help in providing rhIFN-alpha-2A. MEDI545 is a fully human IgG1 anti-interferon alpha antibody that was generated by Medarex in mice transgenic for human immunoglobulin genes.
###end p 19
###begin title 20
References
###end title 20
###begin p 21
###xml 53 54 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 203 204 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 209 210 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 214 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 221 222 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 244 245 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</italic>
###xml 246 247 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 294 295 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 433 434 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 443 444 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 449 450 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 454 445 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 461 462 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 484 485 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</italic>
###xml 486 487 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 570 572 558 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 616 617 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 645 646 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
Crystals of the MEDI545 Fab-rhIFN-alpha-2a complex. (a) Screening. The crystals shown were obtained during the initial screening phase using Crystal Screen HT (Hampton Research) under condition H9 [0.01 M NiCl2.6H2O, 0.1 M Tris-HCl pH 8.5, 20%(w/v) polyethylene glycol monomethyl ether 2000]. (b) Optimization. The crystals shown grew to dimensions of up to 0.1 x 0.1 x 0.2 mm in hanging drops when 1 microl reservoir solution [200 mM NaI, 8 mM NiCl2.6H2O, 80 mM Tris-HCl pH 8.5, 16%(w/v) polyethylene glycol monomethyl ether 2000] was mixed with 1 microl of a 3.5 mg ml-1 MEDI545 Fab-rhIFN-alpha-2A solution in 20 mM sodium acetate pH 5.2, 20 mM NaCl.
###end p 21
###begin p 22
SDS-PAGE profile of a dissolved crystal of the MEDI545 Fab-rhIFN-alpha-2a complex under reducing and nonreducing conditions. The 4-20% gradient gel (BioRad, Hercules, California, USA) was stained with Bio-Safe Coomassie Stain (BioRad). It shows rhIFN-alpha-2a migrating at around 15 and 20 kDa under nonreducing and reducing conditions, respectively. This difference is likely to be attributable to the presence of two internal disulfide bonds, the reduction of which alters the compactness (and thus the migration) of the molecule. The same argument can be applied to the MEDI545 Fab fragment, which migrated slightly under its expected molecular weight of 50 kDa under nonreducing conditions. As expected, its heavy and light chains both migrated at 25 kDa under reducing conditions.
###end p 22
###begin p 23
Diffraction image of a MEDI545 Fab-rhIFN-alpha-2a crystal.
###end p 23
###begin title 24
X-ray diffraction data-collection statistics
###end title 24
###begin p 25
Values in parentheses are for the highest resolution shell.
###end p 25

